Global Dacarbazine for Injection market is entering a transformative growth era driven by expanding cancer treatment demand, improved healthcare infrastructure, and widespread adoption of combination chemotherapy protocols. The market, valued at USD 147.8 million in 2024, is projected to reach USD 198.5 million by 2032, advancing at a CAGR of 3.7%. The U.S. remains the dominant countr... http://24lifesciences.com/dacarbazine-for-injection-market-10568